메뉴 건너뛰기




Volumn 90, Issue 2, 2012, Pages e154-155

Fatal Pneumocystis jirovecii pneumonia following immunosuppressive therapy with rituximab and prednisolone for posterior scleritis

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CASPOFUNGIN; CIPROFLOXACIN; COTRIMOXAZOLE; METHYLPREDNISOLONE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; RANIBIZUMAB; RITUXIMAB;

EID: 80055004172     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2011.02127.x     Document Type: Letter
Times cited : (11)

References (5)
  • 1
    • 77950337482 scopus 로고    scopus 로고
    • Rituximab-associated infections
    • Gea-Banacloche JC, (2010): Rituximab-associated infections. Semin Hematol 47: 187-198.
    • (2010) Semin Hematol , vol.47 , pp. 187-198
    • Gea-Banacloche, J.C.1
  • 2
    • 64749117073 scopus 로고    scopus 로고
    • Rituximab for treatment of ocular inflammatory disease: A series of four cases
    • Kurz PA, Suhler EB, Choi D, &, Rosenbaum JT, (2009): Rituximab for treatment of ocular inflammatory disease: a series of four cases. Br J Ophthalmol 93: 546-548.
    • (2009) Br J Ophthalmol , vol.93 , pp. 546-548
    • Kurz, P.A.1    Suhler, E.B.2    Choi, D.3    Rosenbaum, J.T.4
  • 3
    • 33646480336 scopus 로고    scopus 로고
    • B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection
    • Lund FE, Hollifield M, Schuer K, Lines JL, Randall TD, &, Garvy BA, (2006): B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J Immunol 76: 6147-6154.
    • (2006) J Immunol , vol.76 , pp. 6147-6154
    • Lund, F.E.1    Hollifield, M.2    Schuer, K.3    Lines, J.L.4    Randall, T.D.5    Garvy, B.A.6
  • 4
    • 75649126939 scopus 로고    scopus 로고
    • Value of anti-infective chemoprophylaxis in primary systemic vasculitis: What is the evidence?
    • Moosig F, Holle JU, &, Gross WL, (2009): Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence? Arthritis Res Ther 11: 253-263.
    • (2009) Arthritis Res Ther , vol.11 , pp. 253-263
    • Moosig, F.1    Holle, J.U.2    Gross, W.L.3
  • 5
    • 0037090058 scopus 로고    scopus 로고
    • Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome
    • DOI 10.1086/339548
    • Sepkowitz KA, (2002): Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infec Dis 34: 1098-1107. (Pubitemid 34289683)
    • (2002) Clinical Infectious Diseases , vol.34 , Issue.8 , pp. 1098-1107
    • Sepkowitz, K.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.